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Micro-computed tomography (l-CT) was used to examine the
fidelity of three-dimensional (3D) bioceramic scaffolds made
from dicalcium phosphate dihydrate (DCPD) cement. The
scaffolds were produced with a multi-step indirect solid freeform
fabrication method. Accuracy and fidelity were examined after
each step. The pre-tracing of the perimeter of a layer in the mold
fabrication step caused the round-off of the square channels
from the design. However, the overall shape of the scaffold was
not significantly different from the wax mold. There is relatively
no change in the strut and the channel-size measurements
between the computer-generated model and the molds fabricated
by 3D printing. The change in volume fraction of DCPD cement
scaffolds is higher than biphasic scaffolds due to the internal
pores. These results demonstrated that l-CT is a very useful tool
to analyze and evaluate the internal architectural of the com-
plicated 3D scaffold-fabrication process.
I. Introduction
SCAFFOLD external and internal architectures, including poresize, pore shape, pore distribution, and pore connection, play
important roles in both in vivo and mechanical performance of
the implants. Klein et al.1 showed that macroporosity plays a
role in the rate of bone substitution in dog femora. Several
methods for manufacturing porous calcium phosphate cement
(CPC) with controlled pore channels have been developed.2–4
The ability to design and fabricate controlled scaffold architec-
tures will make it possible to study rigorously how the scaffold
affects bone regeneration. Scaffold architecture design can be
readily accomplished using the image-based design (IBD)
method, which was developed by Hollister et al.5,6 and Taboas
et al.7 to design and optimize scaffold architecture. The compli-
cated designs created by IBD must be manufactured with solid
freeform (SFF) fabrication to control scaffold external shape
and internal pore interconnectivity and geometry. It is impor-
tant to characterize the interior of these scaffolds to assure that
the internal architecture accurately replicates the design with
good fidelity. In this paper, we perform quantitative analysis of
the interior of complex scaffolds using micro-computed tomo-
graphy (m-CT) to assess the fidelity of scaffolds at each stage of
their fabrication. Indirect SFF (ISFF) has been developed by
Chu et al.4,8 The technique enables three-dimensional (3D)
ceramic and polymer–ceramic scaffolds.7 Reilly et al.9 applied
the ISFF method to manipulate 3D electromagnetic bandgap
structures. ISFF fabrication has proven to be a suitable techni-
que for the shaping of complex geometries and advanced design,
which is not possible with conventional manufacturing methods.
Although these complex 3D structures were precisely measured
for the externally visible structures and characterized physically,
the internal structures were not characterized and how well the
fabricated internal architecture replicates the design has not
been rigorously quantified.
Previously, we reported ISFF fabrication for bioceramic
bone–tissue engineering scaffolds10,11 made from dicalcium
phosphate dihydrate (DCPD) cement. CPC is gaining increasing
popularity for bone repair and bone substitution, not only for its
excellent biocompatibility and bone-replacement behavior over
long periods12,13 but also for its similar osteoconductivity to
autologous bone. The first self-setting cement formulations
consisting of calcium phosphates were introduced in 1983 by
Brown and Chow.14 In this present work, we studied DCPD
cement based on b-tricalcium phosphate (b-TCP)–calcium phos-
phate monobasic, monohydrate (MCPM) in an aqueous sys-
tem.15 This cement sets at physiological temperatures, and can
be simply injected into the bone defects; the formulations to be
molded can also be adjusted during the operation. Here, we use
DCPD cement to mold scaffolds with a specific design16 of voids
and struts. Unlike the fluid ceramic slurries in previous work,8,9
the DCPD was a more viscous paste before setting. The complex
3D CPC scaffolds fabricated by the ISFF method were thor-
oughly examined using a nondestructive technique before in vivo
experiments.11 3D m-CT analysis allows us to collect data from
the same specimens to observe and evaluate the complicated
scaffold-fabrication process in order to assess the fidelity of the
fabrication technique.
II. Experimental Procedure
A schematic of scaffold fabrication methods is outlined in
Fig. 1. Five steps are involved: (1) design, leading to a CAD
model; (2) building of the ‘‘lost mold’’ from wax and polysulfo-
namide (PSA) with solid ink-jet printing; (3) dissolution of the
wax to leave the PSA lost mold; (4) casting of the cement
suspension in the PSA mold; and (5) dissolution of the PSA
mold. We use m-CT to examine the fidelity of each step.
(1) Materials
MCPM 99% (Strem Chemicals, Newburyport, MA), and b-
TCP (particle size was around 30 mm, Plasma Biotel Ltd., North
Derbyshire, UK) were used as received. The scaffold molds were
manufactured from PSA (or Protobuildt, Tm 5 851–1071C) and
wax (Protosupportt, Tm 5 601–751C), supplied by SolidScape
(SolidScape Inc., Merrimack, NH). Bioact (Petroferm Inc.,
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Fernanadina Beach, FL) was used to remove the wax. Ethanol
(99%EtOH, Sigma-Aldrich, St. Louis, MO) was used to remove
the PSA.
(2) Computational Design and Scaffold Fabrication
Cylindrical porous scaffolds with 3D orthogonal periodic archi-
tectures were designed using the IBD method developed by
Hollister et al.6 and Lin et al.17 This technique not only allows
the creation of complex internal pore architectures but also
allows the scaffold external shape to match implant site require-
ments using specific image data. The scaffolds were cylindrical
with 8.85 mm diameter and 6.05 mm height, with square
channels (channel size5 650 mm) separated at equal distances
by struts (strut size5 550 mm). This defined orthogonally
branching and interconnected pore channels with a solid volume
fraction of the design5 42%. Note that the solid volume
fraction refers to the fraction of the entire designed scaffold
volume that is occupied by calcium phosphate bioceramic
materials. Figure 2 presents five consecutive steps from design
to finished scaffold: (1) design model, (2) as-built wax molds
(wax1PSA) of the scaffold, (3) dewaxed molds—the PSA lost
mold determines the void channels in the scaffold, (4) cast
molds—with DCPD cement cast around and inside the PSA
lost mold, and (5) scaffold—after removal of PSA, a replica of
the model in set cement.
The scaffold mold design files (Step 1—design model) were
imported into Modelworks software (SolidScape Inc.) for multi-
ple slicing to support a single build, and converted into input
files for 3D printing. Multiple copies of the wax mold (Step 2—
wax mold) were produced using the ModelMaker II rapid
prototyping system (SolidScape Inc.), which constructs models
by sequentially depositing two different materials—molten red
wax, followed by molten green PSA—to make one layer of the
mold. The red wax is deposited to define the areas that will
eventually be calcium phosphate. The green PSA is deposited to
fill the area, which will eventually be pore channels. A horizontal
rotary cutter is used to smooth the top surface, to control the
layer thickness, 0.0508 mm, for this study. The process was
repeated layer by layer until the entire wax mold was con-
structed. Dewaxed molds were obtained by melting the red wax
and removing residual wax in warm Bioact, leaving the green
PSA, which determines the dewaxed mold (Step 3—dewaxed
mold). A suspension was formed from a 1:1 molar ratio of
MCPM and b-TCP powder with varying amounts of distilled
water added. The viscosity of the cement is F100 mPa  s at L/P
(liquid-to-powder) ratio5 1.00. The slip was cast in the dewaxed
molds (Step 4—cast mold) and cured at room temperature
(231C). The cement set within 15 min. The PSA molds were
removed by washing in 70% EtOH and drying in air, resulting
in the finished scaffold (Step 5—scaffold).
(3) Characterization
The interior architectures of the wax molds (Step 2), dewaxed
molds (Step 3), cast molds (Step 4), and scaffolds (Step 5) were
conducted by using an MS-130 high-resolution m-CT scanner
(GE Medical Systems, Toronto, Canada) with a Cu filter at
15 mm voxel resolution, using a shutter speed of 3000 ms, with
a 2 2 bin size, at 100 kV and 110 mA. Each specimen (n5 6)
was sequentially scanned in air. For each sample, a total of 400
micro-tomographic slices were acquired. Measurements were
stored in 3D image arrays with an isotropic voxel size of 15 mm
using GEMS MicroView software (GE Medical Systems). The
reconstructed 3D data sets were used to measure the pore size
and wall size in the x, y, and z directions.
The volume fraction of solid was calculated by defining a
region of interest that covered the entire mold/scaffold, and then
using a thresholding procedure with GEMS MicroView soft-
ware. There is a distinct density difference between the mold
and air, or cement and mold, or cement and air. The density
histogram had a sharp cut-off, so an unambiguous threshold
could be attained.
III. Results and Discussion
Each specimen was scanned in air using m-CT before proceeding
to the subsequent step. The measurements were performed
randomly on each 2D image slide for at least 10 image slides
per specimen in all directions (x, y, and z). Figure 3 illustrates
the slides of reconstructed m-CT images for the interior measure-
ments. Figure 3(a) shows a 2D reconstructed image of the wax
mold (Step 2). The light gray areas indicate PSA, which will
become the pore channels, and the darker contrast represents
wax, which will become the scaffold struts. Note the dark
contrast of voids where the wax was not deposited around
and between the square channels. These voids do not play a
role because the PSA is removed.
The theoretical values for the scaffold dimensions were
calculated from the computer model used to design the molds.
The values of physical measurements (interior channel size and
strut size) of wax molds, dewaxed molds, and cement scaffolds
are summarized in Table I. The wax mold (Step 2) is an accurate
reproduction of the CAD model to within 710 mm of both the
struts (red wax) and the channels (green PSA). The removal of
the wax in Step 3 appears to decrease both the channels and
struts, which could be due to the poor contrast between air (as
the wax was removed) and PSA. However, Student’s t-test was
performed and showed statistically no significance. In Step 4
(cast mold), the measured size of the cement struts is the same as
previous air in Step 3 and statistically the same as the wax mold
and the CAD design. The measured channel size of the PSA is
relatively close to the CAD design. After the PSA removal with
70% EtOH in Step 5, the final scaffold strut size appeared to be
smaller than it was in the cast mold and also smaller than that of
the design by 50 mm (or 10%), while the channel size was larger
than the design by 40 mm (or 6%). The reduction in strut size in
the final step is not clear, although we did not investigate any
chemical reaction of the cement with PSA solution in EtOH. In
contrast, the PSA dissolution in acetone did react with the
porous cement scaffolds, causing the collapse of the scaffold.
However, we conclude that there is relatively no change in the
channel size from the computer-generated model to the molds
physically fabricated by 3D printing. Results demonstrate that
ModelMaker II is capable of accurately creating wax molds with
a channel size of 650 mm, and a strut size of 550 mm correspond-
ing to the designed dimensions (CAD design). It has been shown
that the smallest feature that the ModelMaker II can produce is
18178 mm.18
Computational design of the 
scaffolds 
3D printing to build ‘lost mold’
Wax removal via Bioact: 
‘PSA or dewaxed mold’ 
Cast and cure cement 
suspension at room temperature
PSA removal via EtOH 
Fig. 1. Schematic chart of the indirect solid freeform procedure.
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To examine the change in volume fraction of solid, the
volume of interest was selected within the reconstructed 3D
image from the m-CT scanner and a voxel rendering was
performed for volume–fraction calculations. Figure 4 shows
the image registration of the computer-generated design to the
reconstructed CT image of the wax mold using SolidView/Pro
2003.1 (Solid Concepts Inc.). Figure 4(a) shows the offset from
the center of the wax mold and the design, and the round-off
of the square channels of the fabricated mold. In a rapid
prototype using ModelMaker II, the smooth surface quality
can be achieved by pre-tracing the perimeter of a layer prior to
filling in the interior, which caused the round-off of the square
channel from the design as seen in Fig. 4(a). The conversion of
the CAD model to the STL (stereolithography) format could
cause the mismatch of the fabricated mold from the design. The
STL format (universal RP build format) comprised of a 3D
surface as an assembly of planar triangles and normal vectors
(perpendicular to the surface of the facet, pointing toward the
outside part); thus, they cannot represent curved surfaces ex-
actly. Increasing the number of triangles improves the approx-
imation, but at the cost of a larger file size. Therefore, the
accuracy and manageability need to be balanced. After the
mold-making process, the reconstructed 2D image of DCPD
scaffold was overlaid on the image of the wax mold on the xy
plane and was almost perfectly matched. The struts of the
DCPD scaffold were smaller than the design and were rounded
off similar to the finished mold (Fig. 4(b)). In this study, the size
of a micro-droplet from the spray is 0.076 mm (from the
manufacturer’s specifications) by default.
Figure 5 shows the comparison of the relative volume change
of the solid at each step of the fabrication. There is no change in
volume of the computer model; thus, the relative volume change
of the mold design is 0. A very small discrepancy (B1.4%





Orthogonal design : 
Channel size (pore) = 650 µm
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Fig. 2. Scaffold fabrication by indirect solid freeform: (a) Step 1—cylindrical design mold with 650 mm square channels and 550 mm struts size, (b) Step
2—wax mold fabricated by 3D printing, (c) Step 3—polysulphonamide (PSA) or dewaxed mold, (d) Step 4—cast mold, and (e) Step 5—dicalcium
phosphate dihydrate (DCPD) scaffold after PSA removal.
3178 Journal of the American Ceramic Society—Jongpaiboonkit et al. Vol. 89, No. 10
indicated a good performance of the fabrication method. This
small change in the volume fraction may have to do with the
configuration file for the scaffold layout on the ModelMaker II.
With a layer thickness of 0.0508 mm, the configuration ID
471—each layer is composed of two walls of Protosupportt and
three walls of Protobuildt, and the perimeter support over the
entire part—was suitable for a wide variety of parts and was
selected for this study. Although the finished mold appeared
very solid externally, the inner layers of the wax mold were less
dense because they were temporary supporting structures. The
‘‘smiley faces’’ and several defects (voids) on the reconstructed
m-CT images (Fig. 3) were illustrated as a result of the internally
‘‘less dense’’ layers. The dewaxed molds showed a slight increase
in the volume reduction caused by the dewaxing process. As
mentioned in the experimental procedure, the wax was removed
by melting in the oven at 801–851C for 45 min to 1 h. Note that
the wax and the PSA melt between 501–751C and 951–1071C,
respectively. Residual wax was further removed by washing in
warm Bioact for 30 min and air drying. It is possible that the
melted wax could induce PSA to melt especially at the interface,
causing further reduction of the solid volume fraction. In this
study, two types of calcium phosphate bioceramic scaffold
Fig. 3. Reconstructed micro-computed tomography images for the interior measurements: (a) Step 2—the wax mold, (b) Step 3—the dewaxed mold;
the inverted image is illustrated for better contrast, (c) Step 4—the cast mold (left) and extended view of strut-size measurement (right), and (d) Step 5—
the dicalcium phosphate dihydrate (DCPD) scaffold (left) and pore-size measurement (right).
Table I. Physical Dimensions of Wax Molds, Dewaxed










Step 1: CAD design NA 550 650
Step 2: Wax mold Wax/PSA 550710 650710
Step 3: Dewaxed mold Air/PSA 540710 630720
Step 4: Cast mold DCPD/PSA 540720 645710
Step 5: DCPD scaffold DCPD/air 500720 690725
DCPD, dicalcium phosphate dihydrate; m-CT, micro-computed tomography;
PSA, polysulphonamide; NA, not applicable.
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materials were represented: biphasic calcium phosphate (BCP)
and DCPD cement. For cast BCP, the PSA molds were subject
to a burnout cycle that removed the organic binders and the
mold. Using the same design, the size of the BCPmodel was 1.37
times larger than the DCPD model to account for the shrinkage
of the BCP after sintering. For the DCPD cement scaffold, the
PSA mold was removed by 70% ethanol and air dried. The
presence of the internal pores causes a higher reduction in solid
volume fraction on the DCPD scaffold than in the BCP scaffold.
Note that by applying the ISFF technique with conventional
casting methods, complex geometry and well-controlled internal
architecture can be achieved. Several casting processes have
been demonstrated for a combination of global and local pores7;
therefore, with scaffolds made of other materials, the choice of
solvent for mold dissolution will depend on the cast and mold
materials. For this study, mold removal by solvent dissolution
was the only possible method for non-sintered DCPD cement
scaffolds.
The results obtained by the nondestructive approach allow us
to examine the scaffold artifacts internally. Figure 6 shows the
image of the xz plane of one missing strut of the cast ceramic in
the dewaxed mold, and two more struts were missing on the
same plane after the mold removal. Any missing strut from a
casting error may induce its nearest neighbor to break or erode
during the mold dissolution, hence causing an increase in the
number of missing struts in the finished scaffolds. If there is no
missing strut during the casting, the possibility of obtaining a
perfect scaffold is very high. Table II demonstrates the percen-
tage of good struts formed over the entire scaffold, which is
relatively high (95% or more). These results indicate that the
fabrication of ceramic scaffolds using indirect casting tools
Fig. 4. Three-dimensional (3D) registration images of (a) Step 1—the computer-generated design channel size on the 3D isosurface micro-computed
tomography image of Step 2—the wax mold, and (b) Step 2—wax mold on the isosurface of Step 5—the dicalcium phosphate dihydrate (DCPD)
scaffold on the xy plane. The image registration is performed using SolidView/Pro 2003.1.
Fig. 5. Change in the relative volume fraction of solid. The reduction in
the volume of dicalcium phosphate dihydrate (DCPD) scaffolds (n5 3)
and biphasic calcium phosphate (BCP) scaffolds (n5 3) corresponds to
the internal pores and the shrinkage, respectively.
Fig. 6. Micro-computed tomography images show the missing struts of the cast mold (left) and of the dicalcium phosphate dihydrate (DCPD) scaffold
after mold removal (right).
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offers great potential for the production of complex 3D scaffolds
with micro-interconnected networks. Note that precise struc-
tural control beyond random microporosity with a completely
interconnected pore network has not been achieved by conven-
tional processing techniques.19–22 Based on these results from m-
CT, we can conclude that the indirect scaffold fabrication using
3D printing via the casting technique shows a high potential to
produce accurately the microstructure scaffolds with high-or-
iented pore size and shape internally.
IV. Conclusion
We have demonstrated the application of m-CT to visualize and
thoroughly characterize the internal architecture of manufac-
tured scaffolds from the computer-aided design and rapid
prototyping technologies and assess their porosity. Complex
molds were designed and fabricated in a combination of wax
and thermoplastic materials layer by layer using a commercial
3D printing system. The resolution of the 3D printer is limited
by the nozzle size and the degree of control allowed over the
position controller that defines the print-head movement. This
method is shown to be accurate with 50 mm or about 10% for
nominally 650 mm channels with 550 mm struts. The struts in the
DCPD scaffolds are about 50 mm smaller than the design, with
channels of about 40 mm less than the design (Table II). m-CT
can reveal the presence of the casting defect in the scaffold
interior, results in missing struts. Casting methods and mold
removal are subject to the materials of choice. Taken together,
we demonstrated that the ISFF technique along with casting
methods provide a greater degree of versatility and detail to
scaffold design. These molds can meet specific tissue-engineering
requirements, including the need for mechanical integrity. The
representative DCPD cement scaffold was successfully fabri-
cated and thoroughly characterized internally.
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